second Covid-19 vaccine, which has been named ‘EpiVacCorona,' has completed early-stage human trials few weeks back, according to reports."14 persons were vaccinated during the first phase, and 43 more during the second phase.
Forty-three more volunteers from the placebo control group received a placebo", Rospotrebnadzor Russia's consumer rights protection and human well-being watchdog had earlier said, according to Sputnik News.The watchdog added that all the volunteers taking part in the clinical trials of the Covid-19 vaccine are feeling fine.He also said the volunteers only experienced sensitivity at the injection site, but other than that did not have any side effects.Meanwhile, Russia also expects to register a second vaccine by 15.